ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Phreesia’s Sally Thayer Selected as a Top Woman Leader in Software

Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Sally Thayer, Vice President of Product Management, has been named to The Software Report’s list of the Top 50 Women Leaders in Software of 2024.

Honorees were chosen based on their leadership and contributions to the software industry. This is the seventh consecutive year a female leader from Phreesia has been named to the list. Previous Phreesia awardees include Allison Hoffman, General Counsel; Kristin Roberts, Vice President of Product Management; and Amy VanDuyn, Senior Vice President of Human Resources.

“Much as these companies are breaking down barriers in the business, these women are breaking down borders to help the world develop new, innovative solutions to the world’s software challenges,” The Software Report said in its announcement of the list.

In her role, Sally oversees Phreesia’s patient engagement applications and manages multiple product teams that develop and enhance software to deliver innovative and user-friendly solutions for healthcare organizations. These teams are responsible for patient registration, communication, clinical documentation and user experience (UX), with the UX team formed under Sally’s leadership. Sally is a visionary leader, directing efforts to build, launch and support high-quality products for healthcare organizations and their patients. With more than 20 years of experience in healthcare technology, Sally previously worked in product management with HealthStream and assisted in executing clinical trials. She also served on the institutional review board at Centerstone, one of the nation’s largest behavioral healthcare organizations.

“Being selected as one of the Top Women Leaders in Software is an amazing honor,” said Thayer. “This achievement is a testament to the incredible teams I’ve had the privilege to lead and the supportive environment we’ve built together. I’m very proud of the progress we’re making in the healthcare technology space, as we continue to set new standards of quality and innovation.”

For more information on Phreesia, visit www.phreesia.com.

About Phreesia

Phreesia is the trusted leader in patient activation, giving providers, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled approximately 150 million patient visits in 2023—more than 1 in 10 visits across the U.S.—scale that we believe allows us to make meaningful impact. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives efficiency and improves healthcare outcomes. To learn more, visit phreesia.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  234.42
+0.00 (0.00%)
AAPL  286.19
+0.00 (0.00%)
AMD  215.24
+0.00 (0.00%)
BAC  53.19
+0.00 (0.00%)
GOOG  316.02
+0.00 (0.00%)
META  647.10
+0.00 (0.00%)
MSFT  490.00
+0.00 (0.00%)
NVDA  181.46
+0.00 (0.00%)
ORCL  201.10
+0.00 (0.00%)
TSLA  429.24
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.